Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Controlled Phase III Study of Medial vs. Entire Supraclavicualr Lymph Node Radiation Therapy for Patients With Pathologically Positive Axillary Lymph Node and High Risk of Recurrence After Breast Cancer Surgery

NCT05059379 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05059379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05059379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Controlled Phase III Study of Medial vs. Entire Supraclavicualr Lymph Node Radiation Therapy for Patients With Pathologically Positive Axillary Lymph Node and High Risk of Recurrence After Breast Cancer Surgery
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Recruiting
Start date
September 20, 2021
Completion date
August 31, 2027
Enrollment
1,650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, effect of radiation therapy, radiotherapy; complications